- Home
- RMBI vs CLNN Comparison
RMBI vs CLNN Comparison
Compare RMBI & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMBI | CLNN |
|---|---|---|
| Founded | 1887 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.8M | 120.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | RMBI | CLNN |
|---|---|---|
| Price | $13.98 | $6.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | 24.4K | ★ 315.4K |
| Earning Date | 01-22-2026 | 11-13-2025 |
| Dividend Yield | ★ 4.29% | N/A |
| EPS Growth | ★ 21.88 | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $44,970,551.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $87.58 |
| P/E Ratio | $13.21 | ★ N/A |
| Revenue Growth | ★ 6.42 | N/A |
| 52 Week Low | $11.37 | $2.28 |
| 52 Week High | $15.24 | $13.50 |
Technical Indicators
Market Signals| Indicator | RMBI | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 41.27 |
| Support Level | $14.01 | $6.02 |
| Resistance Level | $14.48 | $6.95 |
| Average True Range (ATR) | 0.32 | 0.61 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 52.22 | 58.39 |
Price Performance
Historical ComparisonAbout RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.